🇺🇸 IV Fentanyl in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Chronic Kidney Disease — 1 report (16.67%)
- Drug Effect Decreased — 1 report (16.67%)
- Rebound Acid Hypersecretion — 1 report (16.67%)
- Renal Failure — 1 report (16.67%)
- Renal Injury — 1 report (16.67%)
- Respiratory Arrest — 1 report (16.67%)
Other Pain Management approved in United States
Frequently asked questions
Is IV Fentanyl approved in United States?
IV Fentanyl does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for IV Fentanyl in United States?
University of Minnesota is the originator. The local marketing authorisation holder may differ — check the official source linked above.